131 related articles for article (PubMed ID: 10086740)
1. TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia.
Avigad S; Kuperstein G; Zilberstein J; Liberzon E; Stark B; Gelernter I; Kodman Y; Luria D; Ash S; Stein J; Goshen Y; Yaniv I; Cohen IJ; Zaizov R
Leukemia; 1999 Mar; 13(3):481-3. PubMed ID: 10086740
[No Abstract] [Full Text] [Related]
2. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the efficacy of two chemotherapy protocols for children with TEL-AML1[STBZ] fusion gene positive acute lymphoblastic leukemia].
Wang KL; Mei YY; Cui L; Gao C; Liu FF; Zhao XX; Li WJ; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Wu MY; Zhou X; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):285-90. PubMed ID: 24762993
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia.
Takahashi Y; Horibe K; Kiyoi H; Miyashita Y; Fukuda M; Mori H; Nozaki C; Hasegawa S; Kawabe T; Kato K; Kojima S; Matuyama T; Naoe T
J Pediatr Hematol Oncol; 1998; 20(3):190-5. PubMed ID: 9628428
[TBL] [Abstract][Full Text] [Related]
5. Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.
Kanerva J; Niini T; Vettenranta K; Riikonen P; Mäkipernaa A; Karhu R; Knuutila S; Saarinen-Pihkala UM
Med Pediatr Oncol; 2001 Nov; 37(5):419-25. PubMed ID: 11745869
[TBL] [Abstract][Full Text] [Related]
6. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification.
Maloney K; McGavran L; Murphy J; Odom L; Stork L; Wei Q; Hunger S
Leukemia; 1999 Nov; 13(11):1708-12. PubMed ID: 10557042
[TBL] [Abstract][Full Text] [Related]
7. The role of TEL fusion genes in pediatric leukemias.
Rubnitz JE; Pui CH; Downing JR
Leukemia; 1999 Jan; 13(1):6-13. PubMed ID: 10049061
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup.
Rubnitz JE; Behm FG; Wichlan D; Ryan C; Sandlund JT; Ribeiro RC; Rivera GK; Hancock ML; Relling MV; Evans WE; Pui CH; Downing JR
Leukemia; 1999 Jan; 13(1):19-21. PubMed ID: 10049054
[TBL] [Abstract][Full Text] [Related]
9. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.
Silverman LB; McLean TW; Gelber RD; Donnelly MJ; Gilliland DG; Tarbell NJ; Sallan SE
Cancer; 1997 Dec; 80(12):2285-95. PubMed ID: 9404706
[TBL] [Abstract][Full Text] [Related]
10. TEL-AML1 positivity in relapsed B cell precursor acute lymphoblastic leukemia in childhood. Berlin-Frankfurt-Münster Study Group.
Seeger K; Buchwald D; Taube T; Peter A; von Stackelberg A; Schmitt G; Köchling J; Henze G
Leukemia; 1999 Sep; 13(9):1469-70. PubMed ID: 10483004
[No Abstract] [Full Text] [Related]
11. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
[TBL] [Abstract][Full Text] [Related]
12. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
13. Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
Bolufer P; Barragán E; Verdeguer A; Cervera J; Fernández JM; Moreno I; Lerma E; Esquembre C; Tasso M; Fuster V; Bermúdez M; Sanz MA
Haematologica; 2002 Jan; 87(1):23-32. PubMed ID: 11801462
[TBL] [Abstract][Full Text] [Related]
14. TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia.
Seeger K; Buchwald D; Peter A; Taube T; von Stackelberg A; Schmitt G; Henze G
Blood; 1999 Jul; 94(1):374-6. PubMed ID: 10428549
[No Abstract] [Full Text] [Related]
15. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
[TBL] [Abstract][Full Text] [Related]
16. Two cases of very late relapsing ALL carrying the TEL:AML1 fusion gene.
Chow CD; Dalla-Pozza L; Gottlieb DJ; Hertzberg MS
Leukemia; 1999 Nov; 13(11):1893-4. PubMed ID: 10557067
[No Abstract] [Full Text] [Related]
17. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
[TBL] [Abstract][Full Text] [Related]
18. TEL/AML-1 fusion gene. its frequency and prognostic significance in childhood acute lymphoblastic leukemia.
Jamil A; Theil KS; Kahwash S; Ruymann FB; Klopfenstein KJ
Cancer Genet Cytogenet; 2000 Oct; 122(2):73-8. PubMed ID: 11106814
[TBL] [Abstract][Full Text] [Related]
19. TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia.
Hubeek I; Ramakers-van Woerden NL; Pieters R; Slater R; Beverloo HB; van Wering ER; Kamps W; Hählen K; Veerman AJ
Br J Haematol; 2001 Apr; 113(1):254-5. PubMed ID: 11328310
[No Abstract] [Full Text] [Related]
20. Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion.
Kanerva J; Saarinen-Pihkala UM; Niini T; Riikonen P; Möttönen M; Mäkipernaa A; Salmi TT; Vettenranta K; Knuutila S
Pediatr Blood Cancer; 2004 Jan; 42(1):30-5. PubMed ID: 14752791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
